MTD Mettler Toledo International Earnings and EPS analysis

EPS in 2025 (TTM): $40.23

Last Report Period Date: Mar 31, 2025

As of July 2025, according to Mettler Toledo International's current financial statements, the company's 12-month EPS is $40.23. Mettler Toledo International's EPS for 2024 amounted to $40.67, marking an increase from $36.1 in 2023. Mettler Toledo International's earnings per share for the quarterly report ending on Mar 31, 2025 reached $7.84.

MTD earnings history

Historical annual and quarterly earnings per share (EPS) data for Mettler Toledo International
EPS (TTM)
$40.23
EPS Growth YoY (Quarterly)
-5.3%
EPS (Quarterly)
$7.84
EPS Growth (Quarterly)
-34.4%

The annual EPS for the year 2024 was $40.67, an increase of 12.7% from $36.1 in 2023. The quarterly per-share earnings for the period ending Mar 31, 2025, was $7.84, indicating a 5.3% decrease from the same quarter last year. MTD's 12-month EPS stands at $40.23 as of March 2025. Mettler Toledo International's annual EPS in 2023 stood at $36.1, a 6.9% decrease year-over-year.

MTD EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-5.3%
EPS growth YoY
12.7%
EPS growth 3Y avg
6.9%
EPS growth 5Y avg
12.2%

During the last 12 months, Mettler Toledo International has seen an EPS growth of -5.3% (YoY, quarterly). Throughout the last three years, the company had an average EPS growth of 6.9% per year. During the last 5 years, the company had an average EPS growth rate of 12.2%. When measured over a ten-year period, MTD's average EPS growth rate was 13.3%.

MTD Earnings Waterfall

Breakdown of revenue, profit and net income for Mettler Toledo International

MTD Earnings vs Peers

What are the earnings of MTD compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
WAT Waters Corp 27.39 -1.1% -1.5% 4.2%
TMO Thermo Fisher Scientific Inc 27.99 6.8% -5.5% 12.4%
MTD Mettler Toledo International Inc 31.42 12.7% 6.9% 12.2%
XYL Xylem Inc 35.64 30.6% 15.7% 10.5%
DHR Danaher Corp 43.44 -17.2% -15.3% 5.3%
BRKR Bruker Corp 80.65 -74% -25.4% -9.8%
BIO Bio-Rad Laboratories Inc N/A -199.5% N/A N/A
HBIO Harvard Bioscience Inc N/A -250% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.